Hepion chair-linked entities buy 6.25M shares

Hepion Pharmaceuticals, Inc. reported insider-related buying of its common stock.

Rhea-AI Filing Summary

Hepion Pharmaceuticals, Inc. reported insider-related buying of its common stock. Entities associated with Executive Chairman and 10% owner Vincent S. LoPriore completed open-market purchases at $0.04 per share on April 21, 2026.

Invictus Capital Advisors Pension Plan bought 1,250,000 shares, bringing its holdings to 6,250,000 shares, while Gravitas Capital LP bought 5,000,000 shares, resulting in 5,000,000 shares held. Footnotes state Mr. LoPriore has voting and investment power over both entities’ positions.

Insider Trade Summary

Net Buyer: 6,250,000 shares

Net Buy 2 txns

Insider LoPriore Vincent S

Role Executive Chairman

Bought 6,250,000 shs ($250K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $0.0001 per share	5,000,000	$0.04	$200K
Purchase	Common Stock, par value $0.0001 per share	1,250,000	$0.04	$50K

Holdings After Transaction: Common Stock, par value $0.0001 per share — 5,000,000 shares (Indirect, By Gravitas Capital LP); Common Stock, par value $0.0001 per share — 6,250,000 shares (Indirect, By Invictus Capital Advisors Pension Plan)

Footnotes (2)

1. F1. Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.
2. F2. Mr. LoPriore is the trustee and beneficiary of the Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity.

Key Figures

Total shares purchased: 6,250,000 shares Purchase price: $0.04 per share Invictus shares bought: 1,250,000 shares +3 more

6 metrics

Total shares purchased 6,250,000 shares Open-market purchases on April 21, 2026

Purchase price $0.04 per share Price for Hepion common stock purchases

Invictus shares bought 1,250,000 shares Invictus Capital Advisors Pension Plan transaction

Invictus holdings after trade 6,250,000 shares Indirect holdings under Invictus plan

Gravitas shares bought 5,000,000 shares Gravitas Capital LP transaction

Gravitas holdings after trade 5,000,000 shares Indirect holdings under Gravitas Capital LP

Key Terms

open-market purchase, indirect ownership, transaction code P, voting and disposition power

4 terms

open-market purchase financial

"transaction_action: "open-market purchase" for both common stock transactions"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

indirect ownership financial

"ownership_type is "indirect" with code "I" for both entries"

transaction code P financial

"transaction_code is "P", described as purchase in open market or private transaction"

voting and disposition power financial

"footnotes state he has the right to vote and dispose of the securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did HEPA report for Vincent S. LoPriore?

Hepion reported entities associated with Vincent S. LoPriore made open-market purchases of common stock. Invictus Capital Advisors Pension Plan and Gravitas Capital LP together acquired 6,250,000 shares at $0.04 per share, increasing their indirect holdings under his voting and investment control.

How many Hepion (HEPA) shares did Invictus Capital Advisors Pension Plan buy?

Invictus Capital Advisors Pension Plan bought 1,250,000 Hepion shares at $0.04 each. After this transaction, it held 6,250,000 shares, with Vincent S. LoPriore as trustee and beneficiary, giving him voting and disposition power over these securities.

What was Gravitas Capital LP’s Hepion (HEPA) purchase and resulting stake?

Gravitas Capital LP purchased 5,000,000 Hepion common shares at $0.04 per share. Following the trade, Gravitas Capital LP held 5,000,000 shares, with Vincent S. LoPriore as managing member holding voting and investment authority over this indirect ownership position.

Were the HEPA insider transactions open-market purchases or awards?

The Hepion transactions were open-market purchases, not stock awards or option exercises. Both entries use transaction code P, described as purchases in open market or private transactions, at a stated price of $0.04 per share for the common stock.

Does Vincent S. LoPriore have voting power over the reported HEPA shares?

Yes. Footnotes explain he is managing member of Gravitas Capital LP and trustee and beneficiary of the Invictus Capital Advisors Pension Plan. In these roles, he holds voting and disposition power over all securities these entities acquired and now hold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 06:24 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LoPriore Vincent S

(Last) (First) (Middle)

C/O HEPION PHARMACEUTICALS, INC.

34 SHREWSBURY AVE., SUITE 1D

(Street)

RED BANK NEW JERSEY 07701

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hepion Pharmaceuticals, Inc. [ HEPA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	04/21/2026		P		5,000,000	A	$0.04	5,000,000	I	By Gravitas Capital LP(1)
Common Stock, par value $0.0001 per share	04/21/2026		P		1,250,000	A	$0.04	6,250,000	I	By Invictus Capital Advisors Pension Plan(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.

2. Mr. LoPriore is the trustee and beneficiary of the Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity.

	/s/ Vincent S. LoPriore	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)